The market-implied odds heavily favor no plague pandemic in 2026 because official surveillance from WHO and CDC shows only sporadic, contained cases of Yersinia pestis in known endemic foci such as Madagascar, the Democratic Republic of Congo, and limited U.S. sites, with no evidence of sustained human-to-human pneumonic transmission or exponential growth. Recent monitoring of the October 2026 Irkutsk laboratory incident, involving one fatal pneumonia case of undetermined etiology, confirmed no secondary infections among nearly 200 contacts after extensive testing and quarantine. Modern antibiotics, rapid diagnostics, and public health infrastructure further constrain outbreak potential compared with historical baselines. While a rare lab accident or undetected zoonotic spillover could theoretically escalate before year-end, current epidemiological indicators and model consensus indicate negligible risk of pandemic thresholds being met.